Brufen, Ibuprofen

1. Introduction to Brufen (Ibuprofen)

1.1 Overview of Brufen as a Nonsteroidal Anti-Inflammatory Drug (NSAID)

Brufen, known globally as ibuprofen, is a widely utilized nonsteroidal anti-inflammatory drug (NSAID) that offers potent analgesic, antipyretic, and anti-inflammatory properties. It is frequently chosen for the relief of mild to moderate pain and the mitigation of inflammatory conditions. Clinicians value its versatility, predictable efficacy, and extensive safety data when used appropriately.

1.2 Historical Development and Clinical Adoption

The introduction of ibuprofen in the 1960s marked a significant advancement in pain management. Originally developed as an alternative to aspirin with fewer gastrointestinal complications, the medication rapidly gained global acceptance. Over subsequent decades, ibuprofen became a cornerstone therapy for acute and chronic inflammatory disorders, fever reduction, and general analgesia.

1.3 Therapeutic Class and Pharmacological Profile

Ibuprofen belongs to the propionic acid class of NSAIDs. Its pharmacological profile includes:

• Inhibition of cyclooxygenase (COX) pathways
• Reduction of prostaglandin-mediated inflammation
• Antipyretic activity through hypothalamic heat regulation
• Analgesic modulation of pain signaling pathways

1.4 Global Availability and Brand/Generic Equivalents

The medication is available under multiple brand names worldwide, with Brufen being one of the most recognized. Additionally, a wide range of generic ibuprofen formulations allows broad accessibility in both prescription and over-the-counter settings. Its global availability underscores its long-standing clinical relevance.

2. Composition and Formulations

2.1 Active Ingredient: Ibuprofen

The active pharmaceutical ingredient is ibuprofen, a synthetic NSAID designed to alleviate inflammation and discomfort by modulating prostaglandin synthesis.

2.2 Available Strengths (200mg, 400mg, 600mg, 800mg)

Tablets and capsules commonly come in 200 mg, 400 mg, 600 mg, and 800 mg strengths. The dosing strength selected depends on patient age, severity of symptoms, and clinical indication.

2.3 Pharmaceutical Forms

Brufen is manufactured in multiple forms to ensure dosing flexibility:

• Tablets and film-coated tablets
• Soft gelatin capsules
• Oral syrups and suspensions for pediatric use
• Topical gels and creams
• Extended-release preparations for prolonged symptom control

2.4 Inactive Ingredients and Excipients

Excipients may include lactose monohydrate, starch, cellulose derivatives, and stabilizing agents. The composition varies by manufacturer but is designed to enhance stability, dissolution, and bioavailability.

2.5 Immediate-Release vs Extended-Release Products

Immediate-release formulations act quickly, making them suitable for acute pain. In contrast, extended-release preparations provide prolonged pain relief and may reduce dosing frequency, particularly useful for chronic inflammatory diseases.

3. How Brufen (Ibuprofen) Works

3.1 Mechanism of Action: COX-1 and COX-2 Inhibition

Ibuprofen exerts its effects by blocking COX-1 and COX-2 enzymes. These enzymes catalyze the formation of prostaglandins responsible for mediating inflammation, pain, and fever.

3.2 Anti-Inflammatory, Antipyretic, and Analgesic Effects

Through COX inhibition, ibuprofen decreases inflammatory signaling, reduces elevated body temperature, and helps alleviate pain of various origins, including musculoskeletal, dental, and gynecological discomfort.

3.3 Impact on Prostaglandin Synthesis

Prostaglandins amplify inflammation and sensitize pain receptors. By reducing their production, ibuprofen mitigates swelling, suppresses inflammatory cascades, and provides analgesic relief.

3.4 Onset of Action and Duration of Effect

Ibuprofen typically begins working within 20–40 minutes, with analgesic effects lasting up to 6–8 hours depending on dose and formulation.

4. Approved Medical Uses

4.1 Pain Relief (Mild to Moderate Pain)

Brufen is highly effective for various pain conditions, including muscle aches, joint pain, dental discomfort, and postoperative pain.

4.2 Treatment of Fever and Febrile Conditions

Ibuprofen reduces fever by resetting the hypothalamic thermostat, making it a preferred choice for both adults and children.

4.3 Management of Inflammatory Disorders

4.3.1 Rheumatoid Arthritis

Brufen decreases joint swelling, stiffness, and pain in patients with rheumatoid arthritis, improving mobility and quality of life.

4.3.2 Osteoarthritis

The medication provides symptomatic relief for degenerative joint pain, often used alongside lifestyle modifications and physiotherapy.

4.3.3 Juvenile Idiopathic Arthritis

Oral suspension formulations cater to pediatric patients requiring reliable anti-inflammatory therapy.

4.4 Musculoskeletal Pain

4.4.1 Back Pain

Ibuprofen alleviates lower back pain caused by strain, postural imbalance, or soft-tissue inflammation.

4.4.2 Sprains, Strains, Sports Injuries

Short-term use reduces swelling and promotes functional recovery in minor athletic injuries.

4.4.3 Postoperative Pain

Brufen is frequently integrated into multimodal pain management regimens following minor surgical procedures.

4.5 Menstrual Pain (Dysmenorrhea)

Ibuprofen is a first-line therapy for menstrual cramps because it reduces prostaglandin-driven uterine contractions.

4.6 Dental Pain and Post-Dental Surgery Pain

The medication provides rapid relief from toothache and post-extraction discomfort.

4.7 Headache and Migraine Relief

It helps mitigate headache intensity by modulating pain pathways and reducing inflammation.

4.8 ENT-related Pain (Earache, Sinus Pain, Sore Throat)

Ibuprofen relieves pain stemming from ear, sinus, and throat inflammation associated with viral or bacterial infections.

5. Off-Label Uses

5.1 Gout-Related Pain Management

Although not the first-line therapy, ibuprofen is sometimes used to reduce acute gout pain and inflammation.

5.2 Soft Tissue Inflammation

Off-label use includes tendonitis, bursitis, and other soft-tissue inflammatory disorders.

5.3 Fever and Pain Relief in Viral Illnesses

It is frequently used to alleviate viral symptoms, though supportive care remains the primary treatment.

5.4 Dysmenorrhea Beyond Standard Dosing Protocols

Some clinicians adjust timing or dosing to optimize relief in severe menstrual pain.

5.5 Pain Management in Certain Neuropathic Conditions

Ibuprofen may provide partial relief in select neuropathic disorders when combined with other agents.

5.6 Use in Minor Post-Vaccination Pain and Fever

It may help reduce mild fever and injection-site soreness after vaccination.

6. Dosage and Administration

6.1 Standard Adult Dosage

The typical adult dose ranges from 200 mg to 400 mg every 4–6 hours as needed.

6.2 Dosage for Children and Adolescents

Dosing is weight-based for pediatric patients. Oral suspensions provide precise measurement for infants and children.

6.3 Maximum Daily Dose Guidelines

• Adults: Do not exceed 3200 mg per day.
• OTC use: Maximum 1200 mg per day unless directed by a physician.

6.4 Dosing Frequency and Timing

Administer at evenly spaced intervals to maintain therapeutic plasma levels.

6.5 Administration With or Without Food

While ibuprofen can be taken without food, ingestion with meals may reduce gastrointestinal discomfort.

6.6 Adjustments for Pain vs Inflammation Treatment

Higher or prolonged doses are often necessary for chronic inflammatory conditions compared to simple analgesia.

6.7 Special Instructions for Liquid Formulations

Shake suspensions well before use and measure with an appropriate dosing device to ensure accuracy.

6.8 Missed Dose Guidance

If a dose is missed, it should be taken promptly unless the next scheduled dose is nearing. Doubling doses is discouraged.

7. Side Effects

7.1 Common Side Effects

7.1.1 Nausea, Vomiting, Abdominal Pain

Mild gastrointestinal distress is frequent but typically transient.

7.1.2 Heartburn, Gastric Discomfort

Gastric irritation may occur due to reduced protective prostaglandins.

7.1.3 Dizziness or Headache

Neurological symptoms are usually mild and self-limiting.

7.1.4 Mild Skin Reactions

Skin irritation, rash, or itching may occasionally develop.

7.2 Less Common Side Effects

These may include fluid retention, mood changes, blurred vision, or tinnitus.

7.3 Serious Side Effects

7.3.1 Gastrointestinal Ulcers and Bleeding

Long-term use increases risks of ulceration, perforation, and GI hemorrhage.

7.3.2 Kidney Impairment

Ibuprofen may compromise renal perfusion, especially in dehydrated or elderly patients.

7.3.3 Liver Function Abnormalities

Rarely, hepatic enzymes elevate, indicating possible liver irritation.

7.3.4 Severe Allergic Reactions and Anaphylaxis

Anaphylactic responses demand urgent medical attention.

7.3.5 Cardiovascular Risks (Heart Attack, Stroke)

High doses or prolonged therapy may elevate cardiovascular risks.

7.4 Long-Term Risks of Chronic Use

Long-term administration increases risks of renal, gastrointestinal, and cardiovascular complications.

8. Drug Interactions

8.1 Interactions With Anticoagulants

Ibuprofen may potentiate bleeding risks when used with warfarin or DOACs.

8.2 Interactions With Antihypertensives

8.2.1 ACE Inhibitors

Reduced antihypertensive efficacy may occur.

8.2.2 ARBs

Combined use may impair renal function in high-risk patients.

8.2.3 Beta-Blockers

Possible attenuation of therapeutic effect.

8.3 Interactions With Diuretics

Volume depletion and reduced diuretic efficacy may occur.

8.4 Interactions With Other NSAIDs and Aspirin

Combining NSAIDs heightens the risk of GI and renal toxicity.

8.5 Corticosteroids and Increased GI Bleeding Risk

Concomitant use significantly elevates bleeding risk.

8.6 Alcohol and Gastric Toxicity

Alcohol intensifies gastric irritation and bleeding tendencies.

8.7 Lithium and Increased Serum Levels

Ibuprofen may raise serum lithium concentrations, risking toxicity.

8.8 Methotrexate Toxicity Risk

Reduced clearance can cause methotrexate accumulation.

8.9 Antidepressants (SSRIs/SNRIs)

Combined use may increase bleeding due to platelet inhibition.

9. Warnings and Important Precautions

9.1 Risks of Gastrointestinal Bleeding and Ulceration

Particularly relevant in older adults or those with prior ulcers.

9.2 Cardiovascular Warning

High doses or long-term use are linked to increased risk of cardiac events.

9.3 Renal Function Impairment

Ibuprofen may exacerbate pre-existing renal disease.

9.4 Liver Toxicity Considerations

Periodic monitoring is advisable for chronic therapy.

9.5 Fluid Retention and Edema

Patients with heart failure require cautious use.

9.6 Asthma and NSAID Sensitivity

Bronchospasm may occur in aspirin-sensitive individuals.

9.7 Avoidance in Dehydration or Severe Illness

Dehydration significantly increases renal toxicity risk.

9.8 Risks Associated With High Dosage or Long-Term Use

Prolonged use increases gastrointestinal, renal, and cardiovascular risks.

10. Contraindications

10.1 Known Hypersensitivity to Ibuprofen or NSAIDs

Allergic responses range from rash to life-threatening anaphylaxis.

10.2 Aspirin-Induced Asthma or NSAID Allergy

Patients with NSAID-sensitive asthma must avoid ibuprofen.

10.3 Active GI Bleeding or Ulcer Disease

Ibuprofen may worsen or reactivate GI bleeding.

10.4 Severe Heart Failure

Fluid retention may destabilize cardiac function.

10.5 Severe Renal Impairment

NSAIDs may precipitate renal failure in compromised kidneys.

10.6 Severe Hepatic Disease

Ibuprofen metabolism may become impaired.

10.7 Pregnancy (Third Trimester)

Contraindicated due to risk of fetal ductus arteriosus closure and labor complications.

11. Careful Administration

11.1 Patients With Renal Dysfunction

Monitor kidney function regularly and avoid dehydration.

11.2 Patients With Hepatic Impairment

Use lower doses and monitor liver enzymes periodically.

11.3 Patients With Hypertension or Cardiovascular Risk

Blood pressure monitoring is essential.

11.4 Patients on Long-Term Medication

Assess drug–drug interaction risks.

11.5 Patients With Gastrointestinal Sensitivity

Consider gastroprotective agents if prolonged NSAID use is required.

12. Administration to Elderly Patients

12.1 Dose Adjustments

Lower initial doses are often recommended to minimize adverse effects.

12.2 Increased Cardiovascular Monitoring

Elderly patients have higher cardiovascular susceptibility.

12.3 Enhanced Sensitivity to Side Effects

Falls, dizziness, and renal impairment occur more frequently in older adults.

13. Administration to Pregnant Women and Nursing Mothers

13.1 Use During Pregnancy

Generally avoided during pregnancy, particularly in the third trimester.

13.2 Potential Fetal Risks

Risks include premature closure of ductus arteriosus and renal dysfunction.

13.3 Administration to Nursing Mothers

Ibuprofen passes into breast milk in minimal amounts and is considered compatible with breastfeeding.

14. Administration to Children

14.1 Pediatric Dosing

Weight-based dosing ensures safe and effective administration.

14.2 Use in Infants

Appropriate for infants over six months unless otherwise instructed by a clinician.

14.3 Risks in Children

Overdose risk is higher if suspensions are incorrectly measured.

15. Overdosage

15.1 Symptoms of Overdose

Symptoms include severe abdominal pain, vomiting, drowsiness, metabolic acidosis, and rarely, seizures.

15.2 Emergency Management

Activated charcoal, gastric lavage, and supportive care may be required.

15.3 Long-Term Effects of Toxicity

Acute renal injury and gastrointestinal bleeding are possible in severe cases.

16. Handling Precautions

16.1 Safe Handling

Ensure tablets remain in original packaging until use.

16.2 Measuring Pediatric Suspensions

Always use calibrated dosing devices rather than household spoons.

16.3 Disposal

Dispose of expired products in accordance with pharmacy guidelines.

17. Storage

17.1 Storage Temperature

Store at room temperature, typically below 25°C.

17.2 Protection From Moisture and Light

Keep containers tightly closed and away from direct sunlight.

17.3 Storage of Liquid Formulations

Once opened, suspensions should be used within the recommended timeframe indicated by the manufacturer.

Brufen, Ibuprofen FAQ